May 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autozone, Rocket Pharmaceuticals and Travelers, on Wednesday.
HIGHLIGHTS
* Autozone Inc AZO.N: JP Morgan cuts target price to $4,200 from $4,350 |
* Rocket Pharmaceuticals RCKT.O: Jefferies cuts to hold from buy |
* Skechers USA Inc SKX.N: TD Cowen cuts to hold from buy |
* Travelers TRV.N: KBW raises target price to $303 from $290 |
* Vail Resorts Inc MTN.N: JP Morgan raises to neutral from underweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Aclaris Therapeutics Inc ACRS.O: Wedbush initiates coverage with outperform rating |
* Aclaris Therapeutics Inc ACRS.O: Wedbush initiates coverage with target price of $8 |
* Advance Auto Parts Inc AAP.N: Roth MKM raises target price to $50 from $40 |
* Anaptysbio Inc ANAB.O: Guggenheim raises target price to $90 from $54 |
* Argenx SE ARGX.O: Wedbush adds stock to its best ideas list |
* Asbury Automotive Group ABG.N: BofA Global Research resumes with buy rating; PT $325 |
* Autozone Inc AZO.N: BMO raises target price to $4,100 from $3,850 |
* Autozone Inc AZO.N: Guggenheim raises target price to $4,100 from $3,850 |
* Autozone Inc AZO.N: JP Morgan cuts target price to $4,200 from $4,350 |
* Autozone Inc AZO.N: Raymond James raises target price to $4,200 from $4,000 |
* Autozone Inc AZO.N: Truist Securities raises target price to $4,038 from $3,995 |
* Autozone Inc AZO.N: UBS raises target price to $4260 from $4025 |
* Axalta AXTA.N: Deutsche Bank cuts target price to $38 from $44 |
* Baidu Inc BIDU.O: JP Morgan cuts target price to $90 from $100 |
* Baldwin Insurance Group Inc BWIN.O: Raymond James cuts target price to $48 from $55 |
* Barings Bdc, Inc BBDC.N: Wells Fargo raises target price to $9.50 from $8.50 |
* Booz Allen Hamilton BAH.N: Barclays cuts target price to $120 from $140 |
* Box Inc BOX.N: Morgan Stanley raises target price to $38 from $35 |
* Box Inc BOX.N: Raymond James raises target price to $42 from $38 |
* Box Inc BOX.N: UBS raises target price to $40 from $37 |
* Bristol-Myers Squibb Co BMY.N: Berenberg cuts target price to $55 from $60 |
* Broadcom Inc AVGO.O: Melius Research raises target price to $283 from $198 |
* Broadcom Inc AVGO.O: Mizuho raises target price to $300 from $250 |
* BWX Technologies Inc BWXT.N: William Blair initiates coverage with outperform rating |
* Centrus Energy Corp LEU.A: William Blair initiates coverage with outperform rating |
* Champion Homes, Inc SKY.N: Barclays cuts target price to $72 from $97 |
* Chemours CC.N: Barclays cuts target price to $13 from $16 |
* Chewy, Inc CHWY.N: Barclays raises target price to $50 from $44 |
* Cleveland-Cliffs Inc CLF.N: GLJ Research cuts target price to $3.91 |
* Cleveland-Cliffs Inc CLF.N: GLJ Research cuts to sell from buy |
* Crowdstrike Holdings, Inc CRWD.O: Barclays raises target price to $500 from $475 |
* CubeSmart CUBE.N: Mizuho raises target price to $43 from $39 |
* DTE Energy Co DTE.N: Jefferies raises target price to $148 from $146 |
* Eastman Chemical Co EMN.N: UBS cuts target price to $107 from $111 |
* Essex Property Trust Inc ESS.N: BMO raises target price to $317 from $315 |
* Expand Energy Corp EXE.O: Piper Sandler raises target price to $139 from $136 |
* Extra Space Storage Inc EXR.N: Mizuho raises target price to $153 from $141 |
* Fedex Corp FDX.N: UBS cuts target price to $311 from $331 |
* Fiserv Inc FI.N: UBS cuts target price to $225 from $255 |
* Genesco Inc GCO.N: Truist Securities initiates coverage with hold rating; PT $23 |
* Gitlab Inc GTLB.O: JP Morgan cuts target price to $58 from $62 |
* Hain Celestial Group Inc HAIN.O: Mizuho cuts target price to $3 from $3.50 |
* Hershey HSY.N: Mizuho cuts target price to $155 from $167 |
* Immatics NV IMTX.O: Deutsche Bank initiates coverage with buy rating; PT $10 |
* Informatica Inc INFA.N: JP Morgan cuts to neutral from overweight; raises PT to $25 from $24 |
* Informatica Inc INFA.N: RBC raises target price to $25 from $22 |
* Informatica Inc INFA.N: Truist Securities cuts to hold from buy |
* Informatica Inc INFA.N: Truist Securities raises PT to $25 from $24 |
* Informatica Inc INFA.N: Wells Fargo raises target price to $25 from $19 |
* Iteos Therapeutics Inc ITOS.O: Wedbush cuts to neutral from outperform |
* Iteos Therapeutics Inc ITOS.O: Wedbush raises target price to $12 from $10 |
* Knight-Swift Transportation Holdings Inc KNX.N: Wells Fargo raises PT to $50 from $46 |
* Kraft Heinz KHC.O: Mizuho cuts target price to $29 from $31 |
* Kronos Worldwide Inc KRO.N: Barclays cuts target price to $7 from $10 |
* Liquidia Corporation LQDA.O: H.C. Wainwright raises target price to $35 from $29 |
* Liquidia Corporation LQDA.O: Wells Fargo raises target price to $23 from $20 |
* Masco MAS.N: Deutsche Bank raises target price to $69 from $59 |
* Mastec Inc MTZ.N: Stifel raises target price to $181 from $171 |
* Mastercard MA.N: UBS raises target price to $660 from $640 |
* Mongodb Inc MDB.O: Guggenheim cuts target price to $235 from $300 |
* Neuropace, Inc NPCE.O: H.C. Wainwright initiates coverage with buy rating and PT $18 |
* Okta Inc OKTA.O: Deutsche Bank raises target price to $110 from $105 |
* Okta Inc OKTA.O: BMO cuts target price to $132 from $135 |
* Okta Inc OKTA.O: Canaccord Genuity raises target price to $115 from $100 |
* Okta Inc OKTA.O: D.A. Davidson cuts target price to $140 from $145 |
* Okta Inc OKTA.O: Guggenheim cuts target price to $138 from $140 |
* Okta Inc OKTA.O: Jefferies cuts target price to $130 from $135 |
* Okta Inc OKTA.O: Mizuho cuts target price to $130 from $135 |
* Okta Inc OKTA.O: Needham raises target price to $125 from $115 |
* Okta Inc OKTA.O: RBC cuts target price to $135 from $143 |
* Okta Inc OKTA.O: Scotiabank raises target price to $115 from $109 |
* Okta Inc OKTA.O: Stifel raises target price to $130 from $120 |
* Okta Inc OKTA.O: TD Cowen raises target price to $115 from $110 |
* Okta Inc OKTA.O: UBS cuts target price to $130 from $150 |
* Okta Inc OKTA.O: Barclays cuts target price to $120 from $135 |
* Okta Inc OKTA.O: Wells Fargo raises target price to $110 from $100 |
* Olin Corporation OLN.N: Barclays cuts target price to $24 from $28 |
* Oxford Industries OXM.N: Truist Securities initiates coverage with hold rating; PT $56 |
* Primo Brands PRMB.N: BofA Global Research initiates coverage with buy rating; PO $42 |
* Privia Health Group Inc PRVA.O: JP Morgan raises target price to $32 from $29 |
* Progressive Corp PGR.N: UBS raises target price to $291 from $285 |
* Public Storage PSA.N: Mizuho raises target price to $309 from $287 |
* PVH Corp PVH.N: UBS raises target price to $150 from $140 |
* Rocket Lab USA Inc RKLB.O: Needham raises target price to $32 from $28 |
* Rocket Lab USA Inc RKLB.O: Stifel raises target price to $34 from $29 |
* Rocket Pharmaceuticals RCKT.O: Jefferies cuts price target to $2.50 from $29 |
* Rocket Pharmaceuticals RCKT.O: Jefferies cuts to hold from buy |
* Rocket Pharmaceuticals RCKT.O: Leerink Partners cuts target price to $8 from $37 |
* Rocket Pharmaceuticals RCKT.O: Leerink Partners cuts to market perform from outperform |
* Rocket Pharmaceuticals RCKT.O: BMO cuts target price to $8 from $30 |
* Rocket Pharmaceuticals RCKT.O: TD Cowen cuts to hold from buy |
* Rubrik Inc RBRK.N: Guggenheim raises target price to $105 from $80 |
* Runway Growth Finance Corp RWAY.O: Wells Fargo cuts target price to $9.50 from $10 |
* Savara Inc SVRA.O: Guggenheim cuts target price to $8 from $9 |
* Savara Inc SVRA.O: Wells Fargo cuts target price to $7 from $8 |
* Semtech Corp SMTC.O: Stifel raises target price to $45 from $42 |
* Skechers USA Inc SKX.N: TD Cowen cuts to hold from buy |
* SM Energy Co SM.N: Raymond James raises target price to $34 from $30 |
* Sonic Automotive Inc SAH.N: Benchmark initiates coverage with buy rating; PT $76 |
* Teladoc Health Inc TDOC.N: BofA Global Research cuts price objective to $7 from $8 |
* The Williams Companies, Inc WMB.N: Wells Fargo raises target price to $67 from $64 |
* Transdigm Group Inc TDG.N: JP Morgan raises target price to $1,480 from $1,450 |
* Travelers TRV.N: KBW raises target price to $303 from $290 |
* Trevi Therapeutics, Inc TRVI.O: H.C. Wainwright initiates coverage with buy rating |
* Tronox Holdings Plc TROX.N: Barclays cuts target price to $8 from $13 |
* Ultragenyx Pharmaceutical Inc RARE.O: William Blair initiates coverage with outperform rating |
* Urban Outfitters Inc URBN.O: UBS raises target price to $75 from $54 |
* Vail Resorts Inc MTN.N: BofA Global Research raises price objective to $175 from $160 |
* Vail Resorts Inc MTN.N: JP Morgan raises to neutral from underweight |
* Valhi VHI.N: Barclays cuts target price to $12 from $20 |
* Vigil Neuroscience Inc VIGL.O: Stifel cuts to hold from buy; cuts PT to $8 from $11 |
* Viper Energy Inc VNOM.O: Raymond James raises target price to $54 from $52 |
* Visa Inc V.N: UBS raises target price to $405 from $395 |
* Washington Trust Bancorp Inc WASH.O: BofA Global Research initiates coverage with neutral rating |
* Washington Trust Bancorp Inc WASH.O: BofA Global Research initiates coverage with PO $28 |
* Westlake Corp WLK.N: Citigroup cuts target price to $85 from $95 |
* Westlake Corp WLK.N: UBS cuts target price to $101 from $118 |
* Y-Mabs Therapeutics Inc YMAB.O: Wedbush cuts target price to $18 from $21 |
* Zebra Technologies Corporation ZBRA.O: Morgan Stanley raises PT to $280 from $245 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.